MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-30-2025
AtriCure Interest Expense 2011-2025 | ATRC
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense AtriCure
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -326 K | -31 K | -537 K | 4.92 M | 4.88 M | 4.11 M | 4.61 M | 2.26 M | 1.8 M | 292 K | 305 K | 566 K | 802 K | 814 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.92 M | -537 K | 1.75 M |
Quarterly Interest Expense AtriCure
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 812 K | -180 K | - | 260 K | 28 K | -82 K | - | -62 K | -123 K | 1.64 M | - | 1.32 M | 1.1 M | 1 M | - | 1.45 M | 1.2 M | 1.19 M | - | 1.23 M | 1.23 M | 1.23 M | - | 1.11 M | 879 K | 862 K | - | 1.25 M | 1.22 M | 820 K | - | 576 K | 564 K | 554 K | - | 530 K | 477 K | 259 K | - | 16 K | 17 K | 18 K | - | 24 K | 29 K | 237 K | - | 123 K | 132 K | 173 K | - | 190 K | 201 K | 224 K | - | 170 K | 172 K | 309 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.64 M | -180 K | 554 K |
Interest Expense of other stocks in the Medical instruments industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Baxter International
BAX
|
408 M | $ 19.32 | 1.05 % | $ 9.85 B |  USA |
 |
Becton, Dickinson and Company
BDX
|
613 M | $ 196.18 | -0.01 % | $ 56.4 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
-1 K | $ 5.47 | -0.01 % | $ 110 M | USA |
 |
Harvard Bioscience
HBIO
|
-227 K | $ 0.71 | -1.78 % | $ 30.1 M | USA |
 |
Alcon
ALC
|
192 M | $ 80.33 | 0.26 % | $ 40.4 B |  Schweiz |
 |
Repro Med Systems
KRMD
|
561 K | $ 6.25 | -3.55 % | $ 285 M | USA |
 |
iRhythm Technologies
IRTC
|
1.25 M | $ 177.0 | 0.68 % | $ 5.52 B | USA |
 |
ICU Medical
ICUI
|
107 M | $ 148.17 | 0.81 % | $ 3.61 B | USA |
 |
LeMaitre Vascular
LMAT
|
205 K | $ 83.95 | -0.46 % | $ 1.88 B | USA |
 |
Atrion Corporation
ATRI
|
149 | - | - | $ 810 M | USA |
 |
electroCore
ECOR
|
6.3 M | $ 4.93 | 1.54 % | $ 27.2 K | USA |
 |
Isoray
ISR
|
2 K | - | 0.03 % | $ 108 M | USA |
 |
AngioDynamics
ANGO
|
4.94 M | $ 13.12 | -0.3 % | $ 536 M | USA |
 |
Merit Medical Systems
MMSI
|
-711 K | $ 87.36 | -0.03 % | $ 5.09 B | USA |
 |
The Cooper Companies
COO
|
-16.4 M | $ 82.55 | -0.03 % | $ 16.4 B | USA |
 |
Glaukos Corporation
GKOS
|
13.6 M | $ 116.08 | -0.56 % | $ 5.62 B | USA |
 |
Haemonetics Corporation
HAE
|
-9.75 M | $ 80.39 | 0.36 % | $ 4.05 B | USA |
 |
InfuSystem Holdings
INFU
|
1.4 M | $ 8.93 | -1.71 % | $ 184 M | USA |
 |
Masimo Corporation
MASI
|
300 K | $ 132.7 | -0.44 % | $ 7.07 B | USA |
 |
OraSure Technologies
OSUR
|
-380 K | $ 2.43 | - | $ 181 M | USA |
 |
Microbot Medical
MBOT
|
2 K | $ 2.16 | -0.88 % | $ 22 M |  Israel |
 |
Milestone Scientific
MLSS
|
60.3 K | $ 0.29 | -1.41 % | $ 23.1 M | USA |
 |
Nephros
NEPH
|
2 K | $ 4.98 | -4.78 % | $ 51.7 M | USA |
 |
STERIS plc
STE
|
8.4 M | $ 255.64 | 0.02 % | $ 25.2 B | USA |
 |
Envista Holdings Corporation
NVST
|
-100 K | $ 21.99 | -0.05 % | $ 3.79 B | USA |
 |
Predictive Oncology
POAI
|
3 | - | - | $ 32.4 M | USA |
 |
Pro-Dex
PDEX
|
533 K | $ 39.33 | -2.65 % | $ 129 M | USA |
 |
Utah Medical Products
UTMD
|
256 K | $ 56.66 | 0.66 % | $ 206 M | USA |
 |
Pulse Biosciences
PLSE
|
983 K | $ 14.45 | -2.76 % | $ 694 M | USA |
 |
ResMed
RMD
|
3.2 M | $ 245.14 | 0.3 % | $ 35.8 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
12 M | $ 11.47 | 3.66 % | $ 2.33 B | USA |
 |
Repligen Corporation
RGEN
|
8.12 M | $ 165.37 | -0.18 % | $ 9.21 M | USA |
 |
BioLife Solutions
BLFS
|
497 K | $ 24.95 | -1.81 % | $ 1.15 B | USA |
 |
Stereotaxis
STXS
|
1.1 M | $ 2.46 | 1.23 % | $ 199 M | USA |
 |
STAAR Surgical Company
STAA
|
815 K | $ 23.37 | -1.1 % | $ 1.15 B | USA |
 |
Retractable Technologies
RVP
|
227 K | $ 0.82 | -0.51 % | $ 24.5 M | USA |
 |
Teleflex Incorporated
TFX
|
57 M | $ 122.75 | 0.7 % | $ 5.75 B | USA |
 |
West Pharmaceutical Services
WST
|
-1 M | $ 274.28 | -0.95 % | $ 20 B | USA |